Viromed Medical AG (VME) Stock Price & News

VME:ETR

Viromed Medical AG

€7.15

-0.69%

(-0.050) 1D

Jun 5, 5:35:24 PM GMT+2 · EUR

All symbols

YTD

MAX

	Symbol	Price	Change	% Change

Generating top insights for VME...

Open

€7.15

High

€7.15

Low

€7.15

Mkt. cap

155.17M

Avg. vol.

8.24K

Volume

0.00

P/E ratio

195.25

52-wk high

€8.45

52-wk low

€3.80

EPS

€0.04

Shares outstanding

21.25M

Open

€7.15

High

€7.15

Low

€7.15

Mkt. cap

155.17M

Avg. vol.

8.24K

Volume

0.00

P/E ratio

195.25

52-wk high

€8.45

52-wk low

€3.80

EPS

€0.04

Shares outstanding

21.25M

Related stocks

PTP

Pentixapharm Holding AG

KraneShares 2x Long BABA Daily ETF

$8.55

-8.46%

News stories

From sources across the web

Yahoo Finance

36 minutes ago

AI Dominance Is Turning the S&P 500 into a Collection of Individual Winners, Says Evercore

Moomoo

1 hour ago

Believe in Daddy

Simply Wall Street

1 hour ago

Why Cintas (CTAS) Is Up 5.0% After Raising Full-Year Guidance On Q3 Earnings Momentum – And What's Next

MarketWatch

12 hours ago

S&P 500 sees $1.8 trillion wipeout, Nasdaq tallies biggest point drop on record: What investors need to know about Friday’s selloff

About Viromed Medical AG

CEO-

Employees-

Founded2021

Headquarters-

SectorHealth care provider

Websiteviromed-medical-ag.de

All values in EUR	Sep 2024	Dec 2024	Mar 2025	Jun 2025
Revenue	-	-	1.21M	1.21M
Cost of goods sold	-225.00	-225.00	451.54K	451.54K
Cost of revenue	-225.00	-225.00	451.54K	451.54K
Research and development expenses	-	-	-	-
Total research and development expenses	-	-	-	-
Selling, general, and admin expenses	-	-	193.18K	193.18K
Operating expense	145.48K	145.48K	1.29M	1.29M
Total operating expenses	145.25K	145.25K	1.74M	1.74M
Operating income	-145.25K	-145.25K	-536.16K	-536.16K
Other non operating income	-	-	-	-
EBT including unusual items	-37.69K	-37.69K	-535.40K	-535.40K
EBT excluding unusual items	-147.69K	-147.69K	-535.40K	-535.40K
Income tax expense	-	-	-126.99K	-126.99K
Effective tax rate	-	-	23.72%	23.72%
Other operating expenses	145.48K	145.48K	975.01K	975.01K
Net income	-37.69K	-37.69K	-408.41K	-408.41K
Net profit margin	-	-	-33.79%	-33.79%
Earnings per share	-	-	-	-
Interest and investment income	3.86K	3.86K	24.73K	24.73K
Interest expense	-6.30K	-6.30K	-23.97K	-23.97K
Net interest expenses	-2.44K	-2.44K	762.00	762.00
Depreciation and amortization charges	-	-	125.19K	125.19K
EBITDA	-	-	-410.97K	-410.97K
Gain or loss from assets sale	-	-	-	-

AI content may include mistakes. Learn more

HelpSend feedbackPrivacy Terms Disclaimer

Finance

Research